Carbios SAS Stocks

7.81Last Updated 27.04.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

€ 156.27M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
7.81
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Strong growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Carbios SAS, a green chemistry company, develops industrial bioprocesses for the biodegradation and bio recycling of polymers in France. The company engages in the production of EVANESTO, an enzymatic biodegradation solution for polylactic acid (PLA) based single-use plastics; and enzymatic recycling of polyethylene terephthalate (PET). It also offers PLA, a biosourced and biodegradable plastic polymer used in food packaging, disposable tableware, and electronics and medical applications; and recycles plastic waste into plastic materials. The company also exports its products. Carbios SAS has a development agreement with Novozymes to produce enzyme for recycling of PET-plastics and fibers. The company was founded in 2011 and is headquartered in Saint-Beauzire, France.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers.

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of ALCRB.PA is 9.0 and suggests 15% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks